193 related articles for article (PubMed ID: 21917055)
1. Distinct subpopulations of epithelial ovarian cancer cells can differentially induce macrophages and T regulatory cells toward a pro-tumor phenotype.
Alvero AB; Montagna MK; Craveiro V; Liu L; Mor G
Am J Reprod Immunol; 2012 Mar; 67(3):256-65. PubMed ID: 21917055
[TBL] [Abstract][Full Text] [Related]
2. Interaction between Treg cells and tumor-associated macrophages in the tumor microenvironment of epithelial ovarian cancer.
Zhu Q; Wu X; Wu Y; Wang X
Oncol Rep; 2016 Dec; 36(6):3472-3478. PubMed ID: 27748885
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast activation proteins-α suppress tumor immunity by regulating T cells and tumor-associated macrophages.
Hou CM; Qu XM; Zhang J; Ding TT; Han W; Ji GC; Zhong ZH; Chen H; Zhang F
Exp Mol Pathol; 2018 Feb; 104(1):29-37. PubMed ID: 29273462
[TBL] [Abstract][Full Text] [Related]
4. Targeting myeloid cells in the tumor microenvironment enhances vaccine efficacy in murine epithelial ovarian cancer.
Khan AN; Kolomeyevskaya N; Singel KL; Grimm MJ; Moysich KB; Daudi S; Grzankowski KS; Lele S; Ylagan L; Webster GA; Abrams SI; Odunsi K; Segal BH
Oncotarget; 2015 May; 6(13):11310-26. PubMed ID: 25888637
[TBL] [Abstract][Full Text] [Related]
5. Influence of ovarian cancer type I and type II microenvironment on the phenotype and function of monocyte-derived dendritic cells.
Surówka J; Wertel I; Okła K; Bednarek W; Tarkowski R; Kotarski J
Clin Transl Oncol; 2017 Dec; 19(12):1489-1497. PubMed ID: 28589429
[TBL] [Abstract][Full Text] [Related]
6. Exosomes Released from Tumor-Associated Macrophages Transfer miRNAs That Induce a Treg/Th17 Cell Imbalance in Epithelial Ovarian Cancer.
Zhou J; Li X; Wu X; Zhang T; Zhu Q; Wang X; Wang H; Wang K; Lin Y; Wang X
Cancer Immunol Res; 2018 Dec; 6(12):1578-1592. PubMed ID: 30396909
[TBL] [Abstract][Full Text] [Related]
7. Natural Killer Cells Response to IL-2 Stimulation Is Distinct between Ascites with the Presence or Absence of Malignant Cells in Ovarian Cancer Patients.
da Silva RF; Yoshida A; Cardozo DM; Jales RM; Paust S; Derchain S; Guimarães F
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28513532
[TBL] [Abstract][Full Text] [Related]
8. Immune response evaluation through determination of type 1, type 2, and type 17 patterns in patients with epithelial ovarian cancer.
Cândido EB; Silva LM; Carvalho AT; Lamaita RM; Filho RM; Cota BD; da Silva-Filho AL
Reprod Sci; 2013 Jul; 20(7):828-37. PubMed ID: 23239818
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of Semaphorin4D indicates poor prognosis and prompts monocyte differentiation toward M2 macrophages in epithelial ovarian cancer.
Chen Y; Zhang L; Lv R; Zhang WQ
Asian Pac J Cancer Prev; 2013; 14(10):5883-90. PubMed ID: 24289594
[TBL] [Abstract][Full Text] [Related]
10. Sub-optimal primary surgery leads to unfavorable immunological changes in ovarian cancer patients.
Nowak M; Głowacka E; Lewkowicz P; Banasik M; Szyłło K; Zimna K; Bednarska K; Klink M
Immunobiology; 2018 Jan; 223(1):1-7. PubMed ID: 29017822
[TBL] [Abstract][Full Text] [Related]
11. Immunosuppression through constitutively activated NF-κB signalling in human ovarian cancer and its reversal by an NF-κB inhibitor.
Nishio H; Yaguchi T; Sugiyama J; Sumimoto H; Umezawa K; Iwata T; Susumu N; Fujii T; Kawamura N; Kobayashi A; Park J; Aoki D; Kawakami Y
Br J Cancer; 2014 Jun; 110(12):2965-74. PubMed ID: 24867687
[TBL] [Abstract][Full Text] [Related]
12. Exosomes derived from hypoxic epithelial ovarian cancer deliver microRNA-940 to induce macrophage M2 polarization.
Chen X; Ying X; Wang X; Wu X; Zhu Q; Wang X
Oncol Rep; 2017 Jul; 38(1):522-528. PubMed ID: 28586039
[TBL] [Abstract][Full Text] [Related]
13. The Association of Peripheral Blood Regulatory T-Cell Concentrations With Epithelial Ovarian Cancer: A Brief Report.
Cannioto RA; Sucheston-Campbell LE; Hampras S; Goode EL; Knutson K; Ness R; Modugno F; Wallace P; Szender JB; Mayor P; Hong CC; Joseph JM; Friel G; Davis W; Nesline M; Eng KH; Edwards RP; Kruszka B; Schmitt K; Odunsi K; Moysich KB
Int J Gynecol Cancer; 2017 Jan; 27(1):11-16. PubMed ID: 27759594
[TBL] [Abstract][Full Text] [Related]
14. PD-L1 expression is associated with tumor-infiltrating T cells and favorable prognosis in high-grade serous ovarian cancer.
Webb JR; Milne K; Kroeger DR; Nelson BH
Gynecol Oncol; 2016 May; 141(2):293-302. PubMed ID: 26972336
[TBL] [Abstract][Full Text] [Related]
15. FPR2 participates in epithelial ovarian cancer (EOC) progression through RhoA-mediated M2 macrophage polarization.
Xie X; He J; Wang Q; Liu Y; Chen W; Shi K
J Ovarian Res; 2021 Dec; 14(1):177. PubMed ID: 34930387
[TBL] [Abstract][Full Text] [Related]
16. Tumor-associated macrophages and the tumor immune microenvironment of primary and recurrent epithelial ovarian cancer.
Ojalvo LS; Thompson ED; Wang TL; Meeker AK; Shih IM; Fader AN; Cimino-Mathews A; Emens LA
Hum Pathol; 2018 Apr; 74():135-147. PubMed ID: 29288043
[TBL] [Abstract][Full Text] [Related]
17. Two microRNA signatures for malignancy and immune infiltration predict overall survival in advanced epithelial ovarian cancer.
Korsunsky I; Parameswaran J; Shapira I; Lovecchio J; Menzin A; Whyte J; Dos Santos L; Liang S; Bhuiya T; Keogh M; Khalili H; Pond C; Liew A; Shih A; Gregersen PK; Lee AT
J Investig Med; 2017 Oct; 65(7):1068-1076. PubMed ID: 28716985
[TBL] [Abstract][Full Text] [Related]
18. Regulatory T lymphocytes and transforming growth factor beta in epithelial ovarian tumors-prognostic significance.
Winkler I; Wilczynska B; Bojarska-Junak A; Gogacz M; Adamiak A; Postawski K; Darmochwal-Kolarz D; Rechberger T; Tabarkiewicz J
J Ovarian Res; 2015 Jun; 8():39. PubMed ID: 26077607
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of immune inhibitory cytokine profiles in epithelial ovarian carcinoma.
Chen LL; Ye F; Lü WG; Yu Y; Chen HZ; Xie X
J Obstet Gynaecol Res; 2009 Apr; 35(2):212-8. PubMed ID: 19335794
[TBL] [Abstract][Full Text] [Related]
20. FoxP3+ regulatory T cells in peripheral blood of patients with epithelial ovarian cancer.
Erfani N; Hamedi-Shahraki M; Rezaeifard S; Haghshenas M; Rasouli M; Samsami Dehaghani A
Iran J Immunol; 2014 Jun; 11(2):105-12. PubMed ID: 24975967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
